Why Deaf People Oppose Using Gene Editing to "Cure" Deafness
By Sarah Katz,
Discover
| 08. 11. 2020
Researchers have figured out how to use a gene-editing tool called CRISPR 2.0 to prevent and treat deafness. But many deaf people are happy the way they are.
Deaf Power Poster
As someone who was born deaf, I’m concerned about the latest application of a gene-editing tool called CRISPR 2.0. And I'm not alone. In June, researchers at Boston Children's Hospital, Harvard and MIT announced that, using mice, they figured out how to use the technology to temporarily “correct” a mutation in the TMC1 gene, which can cause deafness in babies. The work is a monumental step toward reversing hereditary deafness in people with a single injection. It could drastically change the fact that two to three out of every 1,000 U.S. children are born deaf or hard of hearing, according to research completed in 2007.
CRISPR 2.0 is a more precise version of the gene-editing tool CRISPR-Cas9, which works like a pair of molecular scissors. Scientists use it to cut strands of DNA. These scissors are built from the defense mechanisms of bacteria, which chop up and destroy the DNA of viruses to prevent their invasion. And in this recent study, they were able to use the smaller scissors of CRISPR 2.0 created in 2017 — think tweezers...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...